Safety and efficacy of oral febuxostat for treatment of HLA-B*5801-negative gout: a randomized, open-label, multicentre, allopurinol-controlled study

Por Yu, K-H, Lai, J-H, Hsu, P-N, Chen, D-Y, Chen, C-J, Lin, H-Y
Publicado no Scand J Rheumatol (2016)

Does primary tumour volumetry performed early in the course of definitive concomitant chemoradiotherapy for head and neck squamous cell carcinoma improve prediction of primary site...

Por Bhatia, K S S, King, A D, Yu, K-H, Vlantis, A C, Mk Tse, G, Kf Mo, F, Ahuja, A T
Publicado em 2010

Can diffusion-weighted imaging distinguish between normal and squamous cell carcinoma of the palatine tonsil?

Por Bhatia, K S S, King, A D, Yeung, D K W, Mo, F, Vlantis, A C, Yu, K-H, Wong, J K T, Ahuja, A T
Publicado em 2010

A phase II, open-label, multicenter study to evaluate the antitumor efficacy of CO-1.01 as second-line therapy for gemcitabine-refractory patients with stage IV pancreatic adenocar...

Por Li, D., Pant, S., Ryan, D.P., Laheru, D., Bahary, N., Dragovich, T., Hosein, P.J., Rolfe, L., Saif, M.W., LaValle, J., Yu, K.H., Lowery, M.A., Allen, A., O'Reilly, E.M.
Publicado no Pancreatology (2014)

A phase II study of gemcitabine and cisplatin plus sorafenib in patients with advanced biliary adenocarcinomas

Por Lee, J K, Capanu, M, O'Reilly, E M, Ma, J, Chou, J F, Shia, J, Katz, S S, Gansukh, B, Reidy-Lagunes, D, Segal, N H, Yu, K H, Chung, K-Y, Saltz, L B, Abou-Alfa, G K
Publicado em 2013